Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00435396
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2007-02-14
Brief Title:
Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Infections Cytomegalovirus |
Keywords: